Skip to main content

Table 5 Main outcomes in different types of cancer

From: Clinical characteristics, outcomes, and risk factors for mortality in hospitalized patients with COVID-19 and cancer history: a propensity score-matched study

Cancer types

Total

N = 53 (%)b

Dead

N = 27 (%)c

ICU Admission

N = 29(%)d

Intubation

N = 27 (%)e

Hospital stay; days

Median (IQR)

Solid tumors

29 (54.7)

10 (37)

11 (37.9)

10 (37)

6 (2;10)

 Gastrointestinal

14 (26.4)

5 (18.5)

6 (20.7)

5 (18.5)

5.5 (2;11)

 Breast

4 (7.6)

2 (7.4)

2 (6.9)

2 (7.4)

5 (2.5;7.5)

 Lung

5 (9.4)

0

0

0

7 (6;13)

 Genitourinary

5 (9.4)

2 (7.4)

2 (6.9)

2 (7.4)

8 (2;17)

 Laryngeal

1 (1.9)

1 (3.7)

1 (3.5)

1 (3.7)

1

Hematologic cancers

24 (45.28)

17 (63) a

18 (62.1)

17 (63)

6.5 (2;14)

 ALL

3 (5.66)

2 (7.4)

2 (6.9)

2 (7.4)

7 (1;21)

 AML

9 (16.98)

5 (18.5)

5 (17.2)

5 (18.5)

6 (2;13)

 CLL

4 (7.55)

4 (14.8)

4 (13.8)

4 (14.8)

4 (1.5;15.5)

 CML

1 (1.89)

1 (3.7)

1 (3.5)

1 (3.7)

10

 Lymphoma

5 (9.43)

4 (14.8)

4 (13.8)

4 (14.8)

9 (8;15)

 MM

2 (3.77)

1 (3.7)

2 (6.9)

1 (3.7)

5 (1;9)

  1. ALL Acute lymphoblastic leukemia, AML Acute myeloid leukemia, CLL Chronic lymphocytic leukemia, CML Chronic myelogenous leukemia, MM Multiple myeloma
  2. a Mortality was significantly higher in hematologic cancer patients than patients with solid tumor (P value = 0.013)
  3. bPercentage in 53 cancer patients
  4. cPercentage in 27 non-survived cancer patients
  5. dPercentage in 29 ICU admitted cancer patients
  6. ePercentage in 27 intubated cancer patients